Department of Plastic Surgery and Burns Treatment, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Oral and Maxillofacial Surgery, University Hospitals Sussex: St Richard's Hospital, Chichester, West Sussex, UK.
J Surg Oncol. 2022 Sep;126(3):555-562. doi: 10.1002/jso.26898. Epub 2022 Apr 19.
Risk factors for local atypical fibroxanthoma (AFX) recurrence and progression to pleomorphic dermal sarcoma (PDS) have not previously been identified.
To identify risk factors and provide follow-up suggestions for local AFX recurrence and progression to PDS.
A literature search was performed in the PubMed, EMBASE, and Cochrane databases. The PRISMA and MOOSE guidelines were followed. The risks of local AFX recurrence and progression to PDS were presented as Kaplan-Meier plots and risk factors were presented as hazard ratios (HRs) calculated with univariate and multivariate Cox regression.
Five hundred and ninety-eight patients with AFX from 14 studies were included. Age >74 years and male sex significantly increased the risk of local recurrence (HR: 7.31 [95% confidence interval [CI]: 1.78-30.0], p < 0.01 and HR: 2.89 [95% CI: 1.04-8.01], p < 0.05, respectively). There was no difference when comparing wide local excision and Mohs' micrographic surgery (p = 0.89). The risks of local AFX recurrence and progression to PDS after 2 years were <1%.
A more intensive follow-up regimen could be considered in patients >74 years old and males due to the higher risk of local AFX recurrence.
局部非典型纤维黄色瘤(AFX)复发和进展为多形性真皮肉瘤(PDS)的风险因素尚未确定。
确定局部 AFX 复发和进展为 PDS 的风险因素,并提供随访建议。
在 PubMed、EMBASE 和 Cochrane 数据库中进行了文献检索。遵循 PRISMA 和 MOOSE 指南。局部 AFX 复发和进展为 PDS 的风险以 Kaplan-Meier 图呈现,风险因素以单因素和多因素 Cox 回归计算的风险比(HR)呈现。
纳入了来自 14 项研究的 598 例 AFX 患者。年龄>74 岁和男性显著增加了局部复发的风险(HR:7.31 [95%置信区间 [CI]:1.78-30.0],p<0.01 和 HR:2.89 [95% CI:1.04-8.01],p<0.05)。广泛局部切除和 Mohs 显微镜手术之间没有差异(p=0.89)。2 年后局部 AFX 复发和进展为 PDS 的风险<1%。
由于局部 AFX 复发的风险较高,年龄>74 岁和男性患者可以考虑更密集的随访方案。